Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ABUS — Arbutus Biopharma Corp

CIK 861177 NEW YORK, NY

Position in ABUS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,253,048
-$2,518,897 QoQ
Shares Held
261,052
-68.9% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 175 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 31% Shared 0% None 69%

Common Shares in ABUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ABUS ranks #114 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABUS

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,253,048 261,052
2026-03-31 $3,771,945 838,210
2025-12-31 $4,285,218 890,898
2025-06-30 $3,314,777 1,072,744
2025-03-31 $401,175 114,950
2024-12-31 $339,893 103,943
2024-09-30 $753,995 195,843